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SUMMARY 
The guinea pig is an important meat-producing animal in Peru as well as in several other South 
American countries. They are held in different kinds of systems, from the small backyard breeders 
with few animals to the large commercial farms with thousands of guinea pigs. One of the major 
issues at the farms is animals dying of unknown causes. Salmonellosis is often considered as a major 
cause, but samples for confirmation are rarely taken. It has been known for a long time that 
Clostridium difficile (C. difficile) toxins are lethal to guinea pigs. Several studies have also 
investigated and confirmed that treatment with antibiotics is a significant risk factor for development 
of C. difficile infection (CDI) in laboratory animals. C. difficile is a large, anaerobic, gram positive rod 
with two essential virulence factors, toxin A and toxin B. Until now there appear to be no published 
studies or reports on the possible occurrence of CDI in meat producing guinea pigs. The aim of this 
study was to investigate whether C. difficile infection exists in meat producing guinea pigs in the 
highlands of Peru. The study was performed by taking samples from 77 guinea pigs from 15 farms 
with 120-5000 animals on each farm, in the Mantaro valley in Peru. The samples were taken either by 
a rectal swab (22.0 %) or directly from the cecum (77.9 %) at necropsy. The clinical and pathologic 
findings in the selected animals primarily consisted of signs of diarrhea, poor general condition, 
ascites, typhlitis and enteritis. Some of the animals had been treated with antibiotics during the last 
week before the samples were taken. An enzyme immunoassay (EIA) was used to demonstrate the 
presence of C. difficile toxin A and/or B in the samples. One (1) animal was found toxin positive in the 
test. It was a neonate male from a large farm that at necropsy showed lesions consistent with severe 
typhlitis.  
SAMMANFATTNING 
I Peru, liksom i flera andra Sydamerikanska länder är marsvinet ett viktigt köttproducerande djur. De 
hålls i olika system, från små uppfödningar på bakgårdarna med ett fåtal djur till stora kommersiella 
farmer med tusentals marsvin. Djur som dör av okänd anledning är ett av de stora problemen på 
farmerna. Salmonella antas ofta vara orsaken, men prover för konfirmering tas sällan. Det är sedan 
länge känt att toxiner producerade av Clostridium difficile (C. difficile) är dödliga för marsvin. Flera 
studier har undersökt och konfirmerat att antibiotikabehandling är en viktig riskfaktor för utvecklandet 
av C. difficile-infektion (CDI) hos försöksdjur. C. difficile är en stor, anaerob, grampositiv stav med 
två huvudsakliga virulensfaktorer, toxin A och toxin B. Inga tidigare rapporter eller studier över 
förekomst av CDI hos köttproducerande marsvin har påträffats. Syftet med den här studien var att 
undersöka om Clostridium difficile-infektion existerar bland köttproducerande marsvin i de Peruanska 
högländerna. För att studera detta togs prover från 77 marsvin från 15 olika farmer med 120-5000 djur 
per farm, i Mantarodalen i Peru. Proverna togs antingen med en rektalsvabb (22.0 %) eller direkt från 
cecum (77.9 %) i samband med obduktion. De kliniska och patologiska fynden hos de utvalda djuren 
bestod i huvudsak av diarré, nedsatt allmäntillstånd, ascites, tyflit och enterit. Några av djuren hade 
behandlats med antibiotika under veckan före provtagning. En ”enzyme immunoassay” (EIA) 
användes för att påvisa förekomsten av C. difficile toxin A och/eller B i proverna. Ett (1) djur var 
toxinpositivt i testet. Det var en ung hane från en stor farm. Vid obduktionen sågs lesioner 
överensstämmande med kraftig tyflit.  
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INTRODUCTION 
Guinea pigs (Cavia porcellus) are small herbivorous, monogastric rodents that are kept and bred as a 
meat producing animal in Peru and several other countries in South America (FAO, 1997). It is a 
growing industry in Peru with an increasing amount of meat being exported. The guinea pig is an 
important source of nutrients such as proteins for the Andean people, as well as a significant 
socioeconomic factor for the poor rural families. Compared to other livestock the guinea pig is cheaper 
and easier to keep. They are raised according to three principally different systems, the family, the 
family-commercial and the commercial systems. In the family systems the animals are kept at home, 
often in the kitchen or in the backyard and are taken care of by the women and children in the family. 
This type of husbandry is very common. The family-commercial and commercial farms are 
increasingly well organized and larger in size.  
In the larger farms there are often a greater awareness connected with the breeding for traits that affect 
production (FAO, 1997). The animals are of different types and selected and bred with different goals, 
such as numbers of offspring, growth rate and feed conversion, to name a few. In the family held 
systems there is often a negative selection because the biggest/fastest growing animals get eaten or 
sold and the less productive ones are left to reproduce.  
Clostridium difficile (C. difficile), is a gram positive, spore forming, toxin producing anaerobic 
bacterium. C. difficile infection (CDI, formerly known as C. difficile-associated disease (CDAD)) 
may, in humans as well as in several animal species, result in the whole panorama of clinical 
expression from asymptomatic carrier state to fulminant potentially fatal pseudomembranous colitis 
(Keel & Songer, 2006). The symptoms vary by animal species including humans, age groups and other 
characteristics of the population but in general appear as diarrhea following after treatment with 
antibiotics. The bacteria were first found by Hall and O’Toole in 1935 in feces from healthy newborn 
human babies. They found the bacteria difficult to cultivate and named it Bacillus difficilis (B. 
difficilis) due to that trait and its morphology. The high carrier rate among asymptomatic newborns 
made Hall and O’Toole discount the bacteria an important pathogen (Keessen et al., 2011a). Only over 
the last 30 years C. difficile has been recognized as a pathogen, and primarily in humans where it is 
now one of the most important nosocomial diseases. In veterinary medicine it is also now considered 
an important emerging pathogen (Songer, 2004). Most of the studies are done in humans and 
laboratory animals, but the infection has been described in many other species as well.  
The purposes with this study were:  
• To investigate if CDI (i.e. C. difficile toxin production) exists in meat producing guinea pigs in 
the highlands of Peru.  
• To examine what the symptoms are in the farmed guinea pigs with CDI and if that is in 
concordance with previous findings in laboratory guinea pigs.  
• To assess if there is correlation between treatment with antibiotics and the presence of C. 
difficile toxins in feces or cecal contents from guinea pigs.  
 
LITERATURE REVIEW 
Pathogenesis of CDI 
The predisposing factors for development of CDI have been thoroughly investigated in humans. It has 
been postulated that the two main factors for appearance of clinical disease are exposure to the 
pathogen in combination with a disruption of the intestinal flora (Kelly & LaMont, 1998). This is most 
likely true for animals as well. The most important risk factors for humans are hospitalization, 
2 
  
antibiotic treatment and advanced age (Hurley & Nguyen, 2002; Simor et al., 2002). These risk factors 
are not fully evaluated in various animal species, but it is known that for some species, like guinea 
pigs and hamsters, treatment with antibiotics is a significant risk factor for development of CDI 
(Knoop, 1979; Lowe et al., 1980; Rehg, 1980; Rothman, 1981). Other risk factors that have been 
suggested but not proven for animals are, for example in horses, stress, fastening, surgical or medical 
treatment and hospitalization (Båverud et al., 1997; Gustafsson et al., 2004). The results from some 
studies are in conflict, for example if antibiotic treatment is a risk factor for CDI in horses, where a 
strong relation between the two has been shown in some studies (Madewell et al., 1995; Båverud et 
al., 1997) whereas in other investigations antibiotics was not found being a prerequisite for CDI in 
horses (Weese et al., 2006).   
C. difficile has two essential virulence factors, the two large exotoxins toxin A (TcdA) and toxin B 
(TcdB). Only the toxin producing types among the over 400 different C. difficile strains cause CDI 
(Tonna & Welsby, 2005). The two toxins are both cytotoxic and can cause disease on their own, but 
often act synergistically (Poutanen & Simor, 2004). The cytotoxic effect of TcdB is 1000 times more 
potent than that of TcdA (Tonna & Welsby, 2005), but for long TcdB was thought not to be able to 
cause disease on its own (Lyerly et al., 1985). It was shown that TcdA caused damage to the mucosa 
of the intestines and TcdB then seemed to affect the epithelial cells under it (Poutanen & Simor, 
2004). However, after finding TcdB positive, TcdA negative strains that cause disease in humans (al-
Barrak et al., 1999; van den Berg et al., 2004) it was concluded that TcdA is not necessary for 
developing CDI. 
The receptor-binding domains of TcdA and TcdB seem different from each other (von Eichel-Streiber 
et al., 1992). The receptor for TcdA is primarily located on the brush border of some of the intestinal 
epithelial cells. A receptor for TcdB has yet to be demonstrated. TcdA is taken up by endocytosis 
when it binds to the receptor of a cell, and then fuses with a lysosome (Frisch et al., 2003; Pfeifer et 
al., 2003). Through several steps the toxin becomes activated and released into the cytoplasm. TcdB is 
activated in endolysosomes as well, but the exact mechanism is not known (Qa’Dan et al., 2000; 
Pfeifer et al., 2003).  
The toxins exert their effect in several ways. They inactivate Rho GTPases, damage the actin 
cytoskeleton and cause the loss of cell-to-cell contact by disruption of cell adhesion molecules, and 
eventually induce apoptosis (Pothoulakis & LaMont, 2001; Pfeifer et al., 2003). TcdA and TcdB have 
several other direct and indirect effects on cell signaling. The toxins initiate an inflammatory cascade 
involving several proinflammatory interleukins and tumor necrosis factor-alpha. Neutrophils, 
monocytes, macrophages and mast cells also play an important role in the pathogenesis of CDI. TcdA 
causes the macrophages to express cyclooxygenase-2 with production of prostaglandin E2 (Alcantara 
et al., 2001). All this leads to increased secretion of fluid into the intestinal lumen and tissue damage, 
with or without pseudomembrane formation. There is a neural component as well in the pathogenesis 
of CDI (Pothoulakis & LaMont, 2001) wherein TcdA stimulates the release of substance P from 
neurons. Substance P causes degranulation of mast cells as well as having a direct vascular effect, both 
contributing to the inflammation. The toxin also exerts its effect directly in the small intestine where it 
inhibits the release of norepinephrine from sympathetic postganglionic nerve fibers (Xia et al., 2000). 
In addition to TcdA and TcdB a few C. difficile strains produce a binary toxin (CDT) (Perelle et al., 
1997; Gülke et al., 2001; Geric et al., 2006). CDT has been demonstrated to induce fluid accumulation 
in one study (Geric et al., 2006) and is toxic to eukaryotic cells in culture, but the clinical relevance is 
still not known.  
CDI in humans and different animal species 
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Most of the epidemiologic data are from humans (Kessen et al., 2011a). Until quite recently C. 
difficile has not been recognized as a pathogen for animals and prevalence studies done often include 
only a small number of animals and are based on use of different methods for detecting the bacteria 
and its toxins as there is no reference standard. The consequence is large discrepancies in the results 
found in the various studies.   
Humans 
Hall and O’Toole (1935) first found the bacteria and its toxins in healthy newborn babies. Later 
studies have isolated the bacteria in feces from asymptomatic babies with a prevalence as high as 50-
80 % (Bolton et al., 1984; Hurley & Nguyen, 2002). Human neonates seem to be almost completely 
resistant against the C. difficile toxins even when the colonization and level of toxins are as high as 
found in adult humans with severe disease (Larson et al., 1982; Bolton et al., 1984). The carrier rate 
among healthy adults in general is usually found low, around 3 % (Hurley & Nguyen, 2002) with the 
exception of a study where Iizuka et al. (2004) used a RT-PCR method where they found toxigenic 
RNA from C. difficile in approximately 50 % of the 30 asymptomatic adults tested. Probably more 
common is carrier status among asymptomatic patients at hospitals and long-term care facilities where 
the prevalence is about 4-20 % (Johnson et al., 1990; Simor et al., 2002). This is most likely a 
consequence of a higher burden of spores in the environment. Most of the symptomatic humans are 
elderly persons of at least 65 years of age that are hospitalized and have received antibiotic treatment 
(Hurley & Nguyen, 2002; Simor et al., 2002).  
Guinea pigs 
Several early studies regarding C. difficile and CDI were done in laboratory guinea pigs, but to the 
authors knowledge no studies have investigated C. difficile in commercial and/or familiar guinea pig 
farms for food production.  
Snyder (1937) found that the toxin of B. difficilis (now known as C. difficile) was lethal when injected 
subcutaneously in guinea pigs, but was not taken up from the intestines when given orally. The main 
findings were a gelatinous hemorrhagic edema at the injection site, and that the guinea pigs died in 
convulsions that were not seen in the other species tested.  
That several types of antibiotics, among them penicillin, ampicillin and clindamycin, cause typhlitis 
due to C. difficile toxins in guinea pigs has been known for a long time (Lowe et al., 1980; Rehg, 
1980; Rothman, 1981). Rehg (1980) studied a toxin found in the cecum of guinea pigs with 
clindamycin-associated colitis. Most of the animals died after a single subcutaneous injection with 
clindamycin and the cecal filtrate from these animals was lethal to the guinea pigs that were injected 
with it intraperitoneally. The toxin found was neutralized by C. sordelli antitoxin. The C. sordelli 
antitoxin is also known for neutralizing C. difficile toxin (i.e. the toxin could possibly be from C. 
difficile). Another study also demonstrated that guinea pigs injected with clindamycin die from colitis, 
and that the cecal filtrates from these animals contain a cytotoxin that is lethal to other guinea pigs 
(Knoop, 1979). 
Rothman (1981) investigated what caused the colitis and death of guinea pigs after administration of a 
single dose of penicillin. She found a toxin in cecum of the animals that was cytotoxic in cell cultures 
and also lethal to guinea pigs after injection into ileum or cecum. The animals died within 24 hours 
after injection. Congestion and hemorrhage were seen in the cecum. The results strongly indicated that 
the toxin was produced by C. difficile. 
Boot et al. (1989) investigated the presence of C. difficile and its toxins in cases of typhlitis in specific 
pathogen free guinea pigs that had not received antibiotics or any other treatment. They found the C. 
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difficile toxins to be the cause of the spontaneous acute pseudomembranous typhlitis detected in most 
of these animals. Another common finding was normal feces in the rectum, with fecal impaction of the 
first part of the colon. External signs of diarrhea were rarely observed.  
Other species 
Adults 
Of the common laboratory species, the hamster is by far the species most likely to develop CDI after 
treatment with antibiotics because of its high sensitivity to C. difficile toxins (Chang et al., 1978; 
Lyerly et al., 1985). Rats are the least sensitive laboratory animal to C. difficile toxin, and mice are 
between the hamsters and the rats in sensitivity (Lyerly et al., 1985).   
There is a significant association between C. difficile and enterocolitis in horses (Båverud et al., 1997; 
2003; Weese et al., 2001b). In a study by Båverud et al. (2003) 28 % of the horses with antibiotic-
associated diarrhea were positive for C. difficile toxins. In adult healthy horses the reported prevalence 
of C. difficile is generally low, 0-1 % (Jones et al., 1987; al Saif & Brazier, 1996; Weese et al., 2001b; 
Båverud et al., 1997; 2003). In a study of mainly racetrack horses in Canada the estimated prevalence 
of C. difficile was 7 % (Medina-Torres, 2009). 
Whether C. difficile should be considered a pathogen in dogs is a topic of discussion and further 
investigation. The prevalence of C. difficile found in healthy dogs ranges from 10.5-58 %, but there 
are also several reports about the isolation of C. difficile and its toxins in dogs with severe acute, as 
well as chronic, diarrhea, with a significant association between detection of the toxins and symptoms 
of diarrhea (Marks et al., 2002; Borriello et al., 1983; Riley et al., 1991; Lefebvre et al., 2006; Clooten 
et al., 2008; Weese et al., 2001a; Cave et al., 2002).  
The situation for cats seems similar to that as in dogs. C. difficile is found in asymptomatic cats 
(Borriello et al., 1983; Riley et al., 1991; al Saif & Brazier, 1996; Madewell et al., 1999) but there has 
also been indications that C. difficile can cause diarrhea in cats as well (Weese et al., 2001c).  
Neonates 
Toxin resistance seen in human neonates is also observed in neonatal rabbits and hamsters that do not 
seem to be affected by the toxins either (Rolfe & Iaconis, 1983; Eglow et al., 1992; Keel & Songer, 
2007). In contrast, neonates of other species, like piglets, hares and foals are very sensitive to the C. 
difficile toxins (Dabard et al., 1979; Jones et al., 1987; Waters et al., 1998; Songer et al., 2007; Yaeger 
et al., 2007; Debast et al., 2009).  
The reason for this difference in susceptibility between different species is not fully understood. It has 
been implicated that it is dependent on the absence or presence of a significant number of TcdA 
receptors, though newborn rabbits have very few receptors (Eglow et al., 1992; Borriello & Wilcox, 
1998). However, in other studies it was discovered that the binding of toxins in the intestines of 
neonate hamsters is significant and similar to the one that occurs in adult hamsters and piglets, 
implicating that there is another still not discovered factor (Keel & Songer, 2007; Rolfe, 1991).  
Source of infection 
For humans, the most common way of transmission is nosocomial at hospitals and long-term care 
facilities where the prevalence of C. difficile in the environment is high (Simor et al., 2002). The same 
association is not proved for hospitalized animals like dogs, cats and horses even if some studies done 
in horses indicate that it occurs but that community-associated infection is probably more common 
(Madewell et al., 1995; Aroyo et al., 2007).  
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Similar ribotypes of C. difficile are found in humans and animals which implicates that transmission 
between animals and humans is a possibility (Arroyo et al., 2005; Rodriguez-Palacios et al., 2006; 
Keel et al., 2007; Goorhuis et al., 2008; Hammitt et al., 2008; Jhung et al., 2008; Debast et al., 2009; 
Indra et al., 2009). Another explanation could be the fact that C. difficile is a ubiquitous bacteria so the 
source could be common for both the animal and human isolates.  
No exact data were found concerning how fast the toxins are degraded in dead animals but according 
to Bartlett (2008) they seem very resistant. He tested stool specimens that had “been stored in 
unspecified conditions for 4 to 5 years” and found all of them still positive for C. difficile toxins. 
Strains of C. difficile with the same ribotypes commonly found in humans have been isolated from 
food products like meat, vegetables and ready-to-eat salads, but no foodborne outbreaks have been 
reported (al Saif & Brazier, 1996; Rodriguez-Palacios et al., 2007; 2009; Bakri et al., 2009; Songer et 
al., 2009; Jöbstl et al., 2010; Weese et al., 2010). Whether the origin of the organism is from humans 
or animals has to be evaluated further.  
Clinical expression 
The symptoms and the pathologic changes seen in humans and different animal species are largely 
similar. The C. difficile toxins cause an inflammation in the intestines. The distribution of the lesions 
differs among different species and age groups (Rothman, 1981; Jones et al., 1987; Perkins et al., 
1995; Kelly & LaMont, 1998; Waters et al., 1998). For humans the lesions are found in the distal part 
of the colon. In guinea pigs, neonatal pigs and adult horses the main location for the lesions are the 
cecum, and for adult horses with extension to the proximal colon. Two groups differ from the rest, in 
rabbits and foals the lesions are mainly found in the small intestines.  
The clinical signs within a certain species can vary from mild diarrhea to severe pseudomembranous 
colitis and death (Kelly & LaMont, 1998). In humans CDI is often asymptomatic, or with only milder 
diarrhea. Some people develop more or less extensive colitis with watery diarrhea, nausea and 
abdominal pain and in more severe cases pseudomembrane formation is also seen. In the most severe 
cases the disease progresses with complications such as ileus, perforation or megacolon and could be 
life-threatening (Rubin et al., 1995; Kelly & LaMont, 1998).   
In hamsters and guinea pigs the most common findings are typhlitis with accumulation of fluid in the 
cecum, enlargement of the mesenteric lymph nodes, more or less extensive hemorrhage and 
congestion as well as thinning of the epithelium or thickening of the cecal wall (Rothman, 1981; 
Blankenship-Paris et al., 1995). In hamsters, besides the cecal lesions, involvement of the jejunum and 
colon is also seen. Occasionally a fully developed pseudomembranous typhlitis is seen and most of the 
time it leads to the death for the animals (Boot et al., 1989). Rothman (1981) described the moribund 
guinea pigs exhibit signs like: ”ruffling of the fur, unsteady gait and rapid respiration”.  
In piglets additional symptoms like ascites, hydrothorax and dyspnea may be seen (Waters et al., 
1998). Sometimes the animals, guinea pigs as well as piglets, present with obstipation instead of 
diarrhea even if the content in the cecum is watery, most likely because they develop a paralytic ileus 
and toxic megacolon (Boot et al., 1989; Waters et al., 1998).  
Laboratory diagnosis 
There are several ways of diagnosing CDI. All laboratory tests are done on fecal samples and the 
diagnosis is based on either a method for demonstrating the bacteria, the toxins or a combination of 
both. The method used for indicating the presence of C. difficile is stool culture where selective, 
cycloserine-cefoxitin-fructose agar is used (O’Connor et al., 2001). The major disadvantage with only 
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culturing the bacteria is the rather high rate of asymptomatic carriers among some groups (Rolfe & 
Iaconis, 1983; Bolton et al., 1984; Johnson et al., 1990; Kuijper et al., 2006). Even if the bacteria are 
found it is not sufficient evidence to prove that it causes the disease, since some strains of C. difficile 
do not produce toxins (Mathis et al., 1999).  
There is no official reference standard for detection of C. difficile toxins, even if the cell cytotoxicity 
assay (CTA) is often considered the optimal method with its high sensitivity and specificity (Chang et 
al., 1979; Wilkins & Lyerly, 2003; van den Berg et al., 2007). The main disadvantages with that 
method are that it has a rather long turnaround time, at least 24-48 hours, and it requires a laboratory 
with a cell line, which makes it more technically demanding and labour intensive than other tests 
(Chang et al., 1979; Delmée et al., 2005; Ticehurst et al., 2006). 
The most common test for routine diagnosis of CDI in humans as well as in animals is one of the 
many rapid commercial enzyme immunoassays (EIA) available for detecting C. difficile toxin A 
and/or B (Barbut et al., 2003). The advantage of these tests is their quick turnaround time. A result is 
achieved within a few hours. They are also relatively inexpensive, easy to use and do not require 
advanced laboratory equipment. The main disadvantages with using these enzyme immunoassays in 
animals are that they are not fully evaluated for use in animals and that they in some studies, in dogs 
for example, were found having an unacceptably low sensitivity and for several of the assays poor 
specificity (Chouicha & Marks, 2006).  
The EIAs are developed and validated for use in humans. Several studies have investigated the 
sensitivity and specificity for different EIAs when tested on human fecal samples. Rüssmann et al. 
(2007) studied three different EIAs, one of them ProSpectT C. difficile Toxin A/B Microplate Assay, 
and found all of them satisfying in terms of sensitivity (88.3-93.3 %) and specificity (100 %). The 
samples used were human stool specimens from patients with antibiotic-associated diarrhea. Yücesoy 
et al. (2002) tested another EIA and proved that it was as good as the CTA, which means that the 
sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were all 
100 %. In other studies where the same EIA has been used the sensitivity ranged from 83.3-96 %, the 
specificity between 99.3-100 %, the PPV was 100 % and the NPV 90-99.5 % (Lyerly et al., 1998; 
Aldeen et al., 2000). 
The sensitivity and specificity are lower when the EIAs are evaluated in animals like pigs and dogs. 
The sensitivity, specificity, PPV and NPV for pigs in some studies were, respectively: 54.8-91 %, 
31.5-92.6 %, 53.1-86 % and 66.7-86 % (Keessen et al., 2011b; Anderson & Songer, 2008; Post et al., 
2002. Chouicha & Marks (2006) performed two studies with five EIAs. In the first study they tested 
143 fecal specimens from dogs with and without diarrhea and found a sensitivity that ranged from 7-
33 % and a specificity that ranged from 65-100 % compared to the CTA. In the second study they 
tested the same five EIAs on 29 C. difficile isolates cultured from the same 143 fecal samples as used 
before and found a sensitivity of 93 % and a specificity ranging from 87-100 %.  
OBJECTIVES OF THE STUDY 
The primary reason for performing this study was that CDI seems to be overlooked as a potential 
problem in guinea pig production in the Peruvian highlands in spite the fact that it has been proved 
lethal in laboratory guinea pigs and is also the cause of serious problems in humans as well as in 
several other animal species (Rehg, 1980; Rothman, 1981; Boot et al., 1989; Rubin et al., 1995; Kelly 
& LaMont, 1998). A common belief is that the Peruvian guinea pig production has significant 
problems with salmonellosis. In two studies Salmonella spp. was isolated in about 60 % of the animals 
with clinical symptoms and/or pathological lesions consistent with salmonellosis (Matsuura et al., 
2010; Layme et al., 2011) but in another recent study where the prevalence of Salmonella spp. in the 
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guinea pig population was investigated the bacterium was not found in any of the animals studied 
(Ellen Pettersson, data at press: SLU Epsilon 2014). The basis of this study was the theory that all 
morbidity/mortality might not be salmonellosis and the aim was therefore to study whether CDI, that 
can be manifested similar at gross necropsy, exists in the guinea pig population in the Peruvian 
highlands.  
MATERIALS AND METHODS 
Selection of farms and animals 
77 guinea pigs were selected for this study from 15 farms in the Mantaro valley in the Peruvian 
highlands, at an altitude of about 3300 meters, within a distance of 50 km from Huancayo city. The 
samples were collected during October 2013. About 40 farms were visited at least once during this 
period.  
All animals found ill on the visited farms were clinically examined and sampled if they fit the 
inclusion criteria (see below). These samples consisted of a small amount of feces taken with rectal 
swabs from the individual animals (stored in Amies transport medium without charcoal). Samples 
from 17 (22.1 % of the animals included in the study) live guinea pigs were collected this way. 
Animals considered having a poor prognosis were, when possible, sacrificed and underwent gross 
necropsies together with animals found dead, about 150 guinea pigs in total. Of these animals 60 fit 
the inclusion criteria and were sampled by collecting a small amount of cecal material. The necropsies 
were either performed on the farms or at IVITA (Veterinary Institute of Tropical and Highland 
Research), the research station in the Mantaro valley, which is part of the National San Marcos 
University, Peru.  
Inclusion criteria consisted of: live animals with symptoms of diarrhea or a poor general condition 
where CDI could not be ruled out (where no other obvious reason for the condition was observed) and 
necropsied animals that had been dead for less than 24 hours with signs of typhlitis (hemorrhage, 
congestion, hyperplasia of the Peyer’s patches, watery and/or hemorrhagic content in cecum) or with 
signs of generalized enteritis. Animals that did not show any signs of intestinal disease at necropsy but 
had received antibiotics the previous week were also included. All animals fitting the criteria were 
sampled without regard to farm size or the animal’s age or sex.   
At the smallest farms visited, with about 30-120 guinea pigs, no ill or dead animals were found. The 
size of the farms where animals fitting the inclusion criteria were found ranged from about 120 
animals up to 5000 animals. The animals were divided into different age groups according to a local 
system with neonates (cría) = 0-14 days old, growing (recria) = 15-45 days old and adult (engorde and 
reproductor) > 45 days old. In this study there were 11 (14.3 %) neonates, 37 (48.0 %) growing and 29 
(37.7 %) adult animals. Of the 77 animals 48 (62.3 %) were female and 29 (37.7 %) were male. 
Detection of C. difficile toxin 
In this study a rapid solid phase enzyme immunoassay (EIA) (ProSpecTTM C. difficile Toxin A/B 
Microplate Assay. Remel, part of Thermo Fisher Scientific, 12076 Santa Fe Drive, Lenexa, KS 66215, 
USA) was used for detecting the presence of C. difficile toxins A and/or B. Specific antibodies, mouse 
monoclonal anti-Toxin A and rabbit anti-Toxin B antibodies, were used to bind the toxins in the 
microplate wells. Through a few steps, where first an enzyme conjugate (horseradish peroxidase 
labelled goat anti-Toxin A and rabbit anti-Toxin B) and later a substrate (3,3’5,5’-
tetramethylbenzidine) were added, a coloured (yellow) product developed in the positive samples. The 
reaction can be read spectrophotometrically at 450/620 to 650 nm (dual wavelength) or visually on a 
scale from 0 (no color, negative reaction) to 4+ (very distinct yellow) where 1+-4+ are regarded as 
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positive results (presence of toxin A and/or B). In this study the reactions were read visually against a 
white background. The wells were washed and incubated at room temperature (20-25 °C) several 
times during the process. The swabs, when used, were dispensed in the sample diluent in a test tube, 
and otherwise some of the cecal content was put directly in the tube with the diluent when the sample 
was taken from the animal. The samples were stored refrigerated (2-8 °C) and tested within 48 hours, 
or 72 hours if diluted in the diluent. The test was performed according to the manufacturer’s 
instructions.  
Clinical data including use of antibiotics 
A minor survey was also performed on the farms visited. Questions included were about the farm in 
general, such as how many animals they had, occurrence of recent increased morbidity or mortality 
over the last week or month, and if so, possible causes of disease, use of prophylactic antibiotics, as 
well as questions about the individual animals sampled. The individual questions were, for example, 
the age and sex of the animal, how long the animal had been ill, what signs they had observed, if it had 
been administered any treatment and in particular if it had received any antibiotics either as a 
treatment or prophylactic.  
RESULTS 
The answers in the survey showed that it was commonly presumed that the animals died from 
salmonellosis, followed by the owners who had no idea at all. At most farms, except IVITA, a 
diagnosis was normally never established. At IVITA all animals found dead are taken for a gross 
necropsy where they are examined visually. Many of the animals are found with suspected 
salmonellosis during the necropsies with signs of enteritis, often edema (ascites or hydropericardium) 
and inflammatory (often hemorrhagic or necrotizing) changes in various organs like the liver, heart, 
lungs and mesenteric lymph nodes. As samples for further diagnostics are rarely taken the diagnosis is 
seldom substantiated.  
Only two of the 15 farms reported increased morbidity and mortality prior to the farm visits. On one of 
these farms salmonellosis was suspected as the underlying cause, and animals were prophylactically 
administered a mixture of tetracycline, enrofloxacin, florfenicol and sulfaquinoxalin together with 
some other ingredients such as electrolytes and clay, on regular basis. They treated all the animals for 
five consecutive days every fourteenth day. Animals showing signs of illness were given additional 
enrofloxacin. On the other farm all of the guinea pigs had received antibiotics, (enrofloxacin), for five 
days with the last treatment two days before sampling, since the owner had observed an increased 
mortality.  
At 6 of the farms (40.0 %) in this study one or more selected animal had received treatment with 
antibiotics, primarily enrofloxacin, but also tetracycline, florfenicol and sulfaquinoxalin one to several 
times the last week. Eighteen of the sampled animals (23.4 %) had received antibiotics sometime 
during that period. Some animals (5 (6.5 %)) that at necropsy did not show any involvement of the 
gastrointestinal tract, but had received antibiotic treatment as described above, were sampled anyway 
to assess whether C. difficile toxins could be found after antibiotic treatment. 
Out of the 77 samples (Table 1 and Attachment 1), one (1) animal (1.3 %) was found positive for 
Clostridium difficile toxin A and/or B. The animal was a neonate (0-14 d.) male found dead at a large 
farm (around 5000 animals). At gross observation during necropsy it showed signs of severe typhlitis 
with a hemorrhagic cecum with watery content. The animal had not received any treatment and no 
signs of illness had been observed prior to its death.  
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At necropsy twenty-five of the animals in this study (32.5 %) showed signs of typhlitis, including one 
or more of the following: hemorrhage, congestion, hyperplasia of the Peyer’s patches, watery and/or 
hemorrhagic content. Two of the guinea pigs had a more severe typhlitis than the others, one of which 
was found toxin positive. Among the 25 guinea pigs with typhlitis 40.0 % (n=10) also had signs of 
generalized enteritis. In this study 40.0 % (n=30) of the animals showed signs of enteritis without 
affection of the cecum. In addition 3.9 % (n=3) of the included animals had diarrhea but did not 
undergo necropsy.  
Of major importance to this current work are the findings of a companion study about the prevalence 
of Salmonella spp. that was done simultaneously on the farms in the same area by another student who 
was not able to detect a single case of that organism by cultivation of fecal samples (Ellen Pettersson, 
data at press: SLU Epsilon 2014). 
Table 1. Findings at necropsy and at clinical examination in sampled animals 
  Number of animals 
Signs Total Age (N/G/A) 
Sex 
(F/M) 
Given 
antibiotics 
(Y/N) 
Test result  
C. difficile toxin 
(Pos/Neg) 
Necropsied animals 60 9/28/23 36/24 15/45 1/60 
Typhlitis 15 2/8/5 8/7 7/8 1/15 
Typhlitis and enteritis 10 0/7/3 4/6 2/8 0/10 
Enteritis 30 7/12/11 19/11 1/29 0/30 
Other + antibiotics 5 0/1/4 5/0 5/0 0/5 
      Live animals 17 2/9/6 12/5 3/14 0/17 
Poor general condition 14 2/6/6 10/4 3/11 0/14 
Diarrhea 3 0/3/0 2/1 0/3 0/3 
      Total 77 11/37/29 48/29 18/59 1/76 
Explanations: N=neonate, G=growing, A=adult, F=female, M=male, Y=yes, N=no, Pos=positive, Neg=negative.  
 
DISCUSSION 
For the first time (to the author’s knowledge) a guinea pig on a meat producing farm in Peru was 
found positive for C. difficile toxins A and/or B. If the CDI in this animal was primary or secondary to 
something else is not known but the necropsy findings were in concordance with the ones described in 
previous studies in laboratory guinea pigs with CDI so it is possible that the CDI was the cause of this 
animal’s death.  
One of the purposes with this study was to examine what the symptoms are in industrial guinea pigs 
with CDI. Another purpose with the study was to assess if there is a correlation between treatment 
with antibiotics and the occurrence of C. difficile toxins in feces or cecal content from the guinea pigs. 
As only one animal was found positive no significant conclusions could be made in either of these 
matters.  
Worth noticing is that the positive animal was not previously treated with antibiotics, which in several 
species is often considered the most important risk factor. Spontaneous cases of CDI have however 
been described in guinea pigs before (Boot et al., 1989) so it is not unlikely to believe that it exists 
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among the industrial animals as well. It is not known whether any other guinea pig in the same 
building as the positive case was being treated with antibiotics at the moment for the toxin positive 
animal’s death and if this could have had any impact of the case (i.e. by shedding and spreading of the 
bacteria and/or antibiotics in the building). 
In this study the results of the survey show a rather high rate of farms treating their animals with 
antibiotics (40 %). It is somewhat falsely high because farms using antibiotics were selected for 
sampling more often than farms not using it. Only one or two more farms, except the 6 where samples 
were taken, out of the 40 visited reported use of antibiotics in the previous week. 
The importance of the finding of CDI in one single animal is hard to interpret, but it at least indicates 
that the disease exists in the population. The manufacturer of the EIA used stress that a negative result 
in the test does not exclude presence of toxins since the level of toxins in the sample could be below 
the detection limit so it is possible there were false negative results in this study. The EIA used in this 
study is not validated for use in guinea pigs, but when evaluated in other species the specificity in 
most cases is higher than the sensitivity, sometimes approaching 100%. With that in mind it is more 
likely that there might have been false negative rather than false positive results. On the other hand, 
the prevalence of CDI in the Peruvian guinea pig population is not known. If the prevalence is low, the 
positive predictive value (PPV) for the test would be low and therefore a higher risk of false positive 
results. 
Considering the fact that the lesions in the intestines caused by CDI are quite similar at visual 
examination to the ones found in other enteric infections the positive animal in this study is an 
important finding as the treatment and precautions to be considered to prevent the diseases are quite 
different for CDI and various other diseases. Salmonellosis, for example, is thought to be very 
common and is often treated with antibiotics in the highlands. Considering that the other study done at 
the same time (Ellen Pettersson, data at press: SLU Epsilon 2014) was unable to detect Salmonella 
spp. in any single sample and also that one of the most important things to do in case of CDI is to 
withdraw the antibiotics it is highly inappropriate to misinterpret the signs for salmonellosis and 
start/continue antibiotic therapy.  
In the Salmonella spp. prevalence study done by the other student (Ellen Pettersson, data at press: SLU 
Epsilon 2014) both Yersinia spp. and Escherichia coli were cultivated from fecal samples and 
confirmed by API10S. This together with the detection of C. difficile toxins in one animal indicates 
that all morbidity/mortality is not only due to salmonellosis and great care should therefore be taken 
when interpreting clinical and/or pathological findings as all of them, at gross observation, are largely 
similar.  
In this study the main goal was to sample animals with typical cecal lesions, but due to shortage of 
time because of logistic problems only a few animals with the preferred pathologic findings could be 
sampled. Considering this being the first investigation of its kind a broader spectrum of symptoms was 
included in order to see in what type of cases the clostridial toxins could be found. Animals with other 
pathological lesions in their intestines, apart from typhlitis, as well as animals that had received 
antibiotics and were found dead or in a poor bodily condition were included.  
The EIA used in this study has been evaluated in humans with results showing a very good sensitivity 
(93.3 %) and specificity (100 %) compared to the results from different combinations of other 
diagnostic tests (Rüssmann et al., 2007). While these EIA’s have not been evaluated in guinea pigs 
they have in several other animal species. In this study the EIA was chosen for several reasons. First of 
all they are commonly used in routine diagnostics for humans as well as for animals even if the 
sensitivity and specificity are found low in some studies when tested on feces from animals (Post et 
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al., 2002; Anderson & Songer, 2008). Secondly the EIA is easy to use even in a modestly equipped 
laboratory such as the one used in this study. The CTA and stool culture were not an option because 
they require more advanced laboratories not feasible in the Andean highlands.  
Sometimes a low sensitivity and specificity was found when EIA’s were evaluated for use in animals 
(Keessen et al., 2011b). The reason for this is still not known, but inhibitors reducing the binding of 
the toxins have been suggested as well as increased toxin degradation due to protease activity, or 
simply toxin levels too low to detect (Chouicha & Marks, 2006; Anderson & Songer, 2008).  
The results from this study indicate that CDI was associated with typhlitis in the farmed guinea pigs 
similar to the one seen in laboratory animals. This study also suggests that not all the cases of typhlitis 
are caused by C. difficile toxins. But still, the positive case was one of the two animals with the most 
severe lesions in the cecum, most animals only had minor lesions, so CDI should not be forgotten in 
cases of severe typhlitis.  
Whether the C. difficile toxin positive case is truly positive cannot be known for sure. The relatively 
high use of antibiotics at the farms would be expected to result in CDI to a larger extent than found in 
this study. On the other hand enrofloxacin is not the type of antibiotic most commonly associated with 
CDI in guinea pigs. The results found in this study could indicate that the prevalence of C. difficile is 
low in the Peruvian guinea pig population which together with a suspected low sensitivity and 
specificity for the EIA used would make the PPV unreliably low, meaning the risk for false positive 
results is high. However, as the prevalence is not known, it could be much higher than indicated in this 
study. For example, if it had been possible to choose the sampled animals with greater care (i.e. only 
those with severe typhlitis) the number of toxin positive animals could have been higher, which in turn 
would make the PPV much higher and significantly lower the risk for false positives. With a narrower 
selection, focusing only on animals with pronounced signs of typhlitis, it is likely that a higher 
frequency of CDI would be demonstrated. 
CONCLUSIONS 
One animal was found positive for TcdA and/or TcdB in this study. It was a neonate male with the 
same pathologic findings as earlier described for laboratory guinea pigs with CDI. The macroscopic 
findings at necropsy together with the positive result of the EIA indicates that CDI actually exists in 
meat producing guinea pigs in the Peruvian highlands but one has to bear in mind that there is a 
possibility that the result could have been false positive. Further studies focusing on guinea pigs with 
pronounced signs of typhlitis are therefore required and would further elucidate to what extent CDI is 
a problem in the Peruvian guinea pig production.  
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APPENDIX 1 
 
Table 2. Findings at necropsy and at clinical examination in sampled animals 
Nr Age Sex Necropsy/live Symptoms Antibiotics Test result 
(EIA) 
1 Adult Female Necropsy Enteritis No Negative 
2 Adult Male Necropsy Enteritis No Negative 
3 Adult Female Necropsy Enteritis, ascites No Negative 
4 Growing Male Necropsy Enteritis No Negative 
5 Adult Female Necropsy Enteritis No Negative 
6 Adult Female Necropsy Enteritis No Negative 
7 Growing Male Live Diarrhea, paralysed 
hindlimbs 
No Negative 
8 Growing Female Live Hemorrhagic diarrhea No Negative 
9 Adult Male Live Poor general condition No Negative 
10 Growing Female Live Poor general condition No Negative 
11 Growing Female Necropsy Enteritis No Negative 
12 Growing Female Necropsy Enteritis No Negative 
13 Growing Female Live Poor general condition, 
growth retardation 
Yes1 Negative 
14 Neonate Male Live Poor general condition, 
artritis 
No Negative 
15 Neonate Female Live Poor general condition No Negative 
16 Adult Female Live Poor general condition, 
ascites 
No Negative 
17 Adult Female Live Poor general condition, 
ascites 
No Negative 
18 Adult Female Live Poor general condition No Negative 
19 Neonate Female Necropsy Enteritis No Negative 
20 Adult Female Necropsy Enteritis Yes2 Negative 
21 Adult Female Live Poor general condition No Negative 
22 Adult Female Necropsy Enteritis No Negative 
23 Neonate Male Necropsy Typhlitis No Negative 
24 Growing Male Necropsy Enteritis No Negative 
25 Growing Female Necropsy Enteritis No Negative 
26 Growing Female Necropsy Enteritis No Negative 
27 Growing Female Live Poor general condition No Negative 
28 Growing Male Live Poor general condition No Negative 
29 Growing Male Necropsy Enteritis No Negative 
30 Growing Male Necropsy Typhlitis No Negative 
31 Neonate Male Necropsy Enteritis No Negative 
32 Neonate Female Necropsy Enteritis No Negative 
33 Neonate Female Necropsy Enteritis No Negative 
20 
  
34 Adult Female Necropsy Enteritis No Negative 
35 Neonate Male Necropsy Typhlitis No Positive, 2+ 
36 Adult Female Necropsy Typhlitis No Negative 
37 Growing Male Necropsy Typhlitis No Negative 
38 Adult Female Necropsy Enteritis, typhlitis No Negative 
39 Growing Male Necropsy Typhlitis No Negative 
40 Growing Male Live Poor general condition No Negative 
41 Growing Female Live Diarrhea, poor general 
condition 
No Negative 
42 Growing Male Necropsy Enteritis, typhlitis No Negative 
43 Growing Male Necropsy Enteritis No Negative 
44 Growing Male Necropsy Typhlitis No Negative 
45 Adult Female Necropsy Enteritis No Negative 
46 Growing Male Necropsy Enteritis, typhlitis No Negative 
47 Growing Male Necropsy Enteritis No Negative 
48 Growing Male Necropsy Enteritis No Negative 
49 Growing Female Necropsy Enteritis No Negative 
50 Adult Female Necropsy Enteritis, typhlitis No Negative 
51 Adult Female Necropsy Enteritis, typhlitis, ruptured 
intestines 
No Negative 
52 Adult Female Necropsy Enteritis, massive ascites No Negative 
53 Growing Male Necropsy Enteritis, typhlitis No Negative 
54 Growing Male Necropsy Typhlitis No Negative 
55 Growing Male Necropsy Enteritis No Negative 
56 Growing Female Necropsy Typhlitis Yes3 Negative 
57 Adult Female Necropsy Severe typhlitis, ascites Yes3 Negative 
58 Growing Male Necropsy Enteritis, typhlitis Yes3 Negative 
59 Growing Female Necropsy Typhlitis Yes3 Negative 
60 Growing Male Necropsy Enteritis, typhlitis Yes3 Negative 
61 Growing Female Necropsy Typhlitis Yes3 Negative 
62 Adult Female Necropsy Pneumonia Yes3 Negative 
63 Growing Female Live Slightly poor general 
condition 
Yes4 Negative 
64 Growing Female Necropsy No necropsy findings Yes4 Negative 
65 Adult Female Live Slightly poor general 
condition, increased 
mortality in the box 
Yes3 Negative 
66 Adult Female Necropsy Lethargy, ascites, hepato- 
and splenomegaly 
Yes5 Negative 
67 Adult Female Necropsy Pneumonia Yes6 Negative 
68 Adult Female Necropsy Typhlitis Yes7 Negative 
69 Adult Female Necropsy Typhlitis, ascites, peritonitis Yes7 Negative 
70 Adult Female Necropsy Typhlitis Yes8 Negative 
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71 Adult Female Necropsy Gas extended intestines, 
ileus? Suspected megacolon. 
Yes8 Negative 
72 Growing Male Necropsy Enteritis, typhlitis No Negative 
73 Adult Female Necropsy Enteritis No Negative 
74 Growing Female Necropsy Enteritis, typhlitis No Negative 
75 Neonate Male Necropsy Enteritis No Negative 
76 Neonate Female Necropsy Enteritis No Negative 
77 Neonate Male Necropsy Enteritis No Negative 
Explanations: 1. Enrofloxacin (Ef) prophylactic one or two times per month, last time two days ago. 2. Treated with Ef the 
last four days. 3. Ef prophylactic every 14th day, last time four days ago. 4. Ef prophylactic every 14th day, last time one day 
ago. 5. Single dose of Ef the same day. 6. Ef for the last five days, increased mortality at the farm. 7. Ef for five days, last 
time two days ago, increased mortality at the farm. 8. Ef for six days, last time seven days ago, increased mortality at the 
farm.   
 
 
